• Clinical evaluation of new drugs in the field of diabetes and diabetes associated diseases
  • Pharmacokinetic studies (especial antidiabetic and antihypertensive drugs, lipid lowering agents)
  • Evaluation of new biomarker or laboratory parameters
  • Testing of new medical – technical products
  • Performing studies according to ICH-GCP criteria
  • Efficient recruitment of patients, which is provided by a large database of patients with type 1 and type 2 diabetes and
  • by access to a network of study interested GP´s
  • Presentation of the study results on national and international scientific congresses
  • Publication of study results in scientific journals
  • Organization of meetings/workshops
A list of studies performed in last years is shown here